Hertz Global Holdings (NYSE:HTZ) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research note issued on Tuesday. They currently have a $26.10 target price on the stock. Zacks‘s target price suggests a potential downside of 5.43% from the stock’s previous close. Hertz Global Holdings, Inc. (NYSE:HTZ) belongs to Services sector. Its net profit margin is 6.50% and weekly performance is -0.69%. On last trading day company shares ended up $27.51. Hertz Global Holdings, Inc. (NYSE:HTZ) distance from 50-day simple moving average (SMA50) is -4.46%.

IAMGOLD Corp. (NYSE: IAG) provided an update from its ongoing exploration program at its newly optioned Monster Lake project located 50 kilometres southwest of Chibougamau, Quebec, Canada. IAMGOLD Corp. (NYSE:IAG) shares fell -2.65% in last trading session and ended the day at $3.30. IAG Gross Margin is 20.30% and its return on assets is -18.60%. IAMGOLD Corp. (NYSE:IAG) quarterly performance is -18.52%.

Repros Therapeutics Inc. (NASDAQ:RPRX) is up almost 20% during trading, on news of successful trial results for its low testosterone treating drug. The trial of the drug was being conducted against a leading treatment of low testosterone and a placebo with two primary end-points. Repros’s drug Androxal showed better results in both measures of the trial and also had statistically significant results for the secondary endpoints. On 17 September, Repros Therapeutics Inc. (NASDAQ:RPRX) shares fell -10.49% and was closed at $12.88. RPRX EPS growth in last 5 year was 29.30%. Repros Therapeutics Inc. (NASDAQ:RPRX) year to date (YTD) performance is -29.62%.

Rocket Fuel (NASDAQ:FUEL) had its price target upped by Evercore Partners from $15.00 to $17.00 in a research note issued to investors on Friday. The firm currently has an equal weight rating on the stock. Rocket Fuel Inc. (NASDAQ:FUEL) ended the last trading day at $15.45. Company weekly volatility is calculated as 11.15% and price to cash ratio as 2.72. Rocket Fuel Inc. (NASDAQ:FUEL) showed a weekly performance of 6.19%.

Leading genomic-based clinical laboratory services provider Genomic Health Inc. (NASDAQ:GHDX) recently reported positive outcome of a health economic analysis that were also published in peer-reviewed medical journal PharmacoEconomics. Genomic Health Inc. (NASDAQ:GHDX) shares increased 0.97% in last trading session and ended the day at $29.22. GHDX Gross Margin is 83.10% and its return on assets is -11.90%. Genomic Health Inc. (NASDAQ:GHDX) quarterly performance is 4.39%.